Concomitant utilization of PERCOCET with CYP3A4 inducers or discontinuation of an CYP3A4 inhibitor could minimize oxycodone hydrochloride plasma concentrations, reduce opioid efficacy or, maybe, result in a withdrawal syndrome in a client who experienced produced physical dependence to oxycodone hydrochloride. Instruct people not to share PERCOCET with Some others also https://jeffb329acd9.wikipowell.com/user